Anderson Daniel Griffith
Director at Sigilon Therapeutics, Inc.
- Sold, on record
- $2M
- Dollars the filings state
- Form 4 sales
- 1
- Latest Jun 2, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Sigilon Therapeutics, Inc.Director
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Sigilon Therapeutics, Inc.Plan not statedJun 2, 2021 2021
Sold 200,000 shares at $10.00 ($2M)
Anderson Daniel Griffith, Director
Sold 9% of holdings ($22.2M position)2M shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (1)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2021 | Jun 4, 2021 | Sigilon Therapeutics, Inc. | Director | Form 4 sale | 200,000 | $2M | 9.0% | Plan not stated | SEC |